Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
208.03
-1.20 (-0.58%)
Jul 30, 2026, 4:00 PM EDT - Market closed
Biogen Stock Forecast
Stock Price Forecast
According to 36 analysts polled by S&P Global, Biogen stock has a consensus rating of "Buy" and an average price target of $233.87. The average 1-year stock price forecast is 12.42% higher than the current stock price, while the lowest is $157 (-24.53%) and the highest is $300 (+44.21%).
Price Target: $233.87 (+12.42%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Biogen stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 14 | 17 | 18 | 18 | 20 |
| Buy | 1 | 1 | 2 | 2 | 3 | 3 |
| Hold | 20 | 20 | 16 | 15 | 14 | 12 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 36 | 36 | 36 | 36 | 36 | 36 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains $255 | Buy | Maintains | $255 | +22.58% | Jul 30, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $237 → $251 | Buy | Reiterates | $237 → $251 | +20.66% | Jul 30, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 30, 2026 |
| UBS | UBS | Buy Maintains $225 → $240 | Buy | Maintains | $225 → $240 | +15.37% | Jul 30, 2026 |
| BMO Capital | BMO Capital | Hold Reiterates $196 → $208 | Hold | Reiterates | $196 → $208 | -0.01% | Jul 30, 2026 |
Financial Forecast
Revenue This Year
10.37B
from 9.89B
Increased by 4.87%
Revenue Next Year
10.55B
from 10.37B
Increased by 1.75%
EPS This Year
12.46
from 15.28
Decreased by -18.48%
EPS Next Year
16.58
from 12.46
Increased by 33.07%
EPS and Forward PE are based on non-GAAP adjusted numbers.